| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.41 | 0.2 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.39 | 0.09 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.28 | 0.3 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.28 | 0.2 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.01 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.23 | 0.3 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.0001 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.22 | 6e-07 |